International Patent: CHIMERIC ANTIGEN RECEPTOR TARGETING CLDN18.2 AND USE THEREOF

GENEVA, July 9 -- SHANGHAI YILING PHARMACEUTICAL CO., LTD filed a patent application (CN2025/147752) for “CHIMERIC ANTIGEN RECEPTOR TARGETING CLDN18.2 AND USE THEREOF”. With publication no. WO/2026/145642, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 19/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....